George Mason University, Center for Applied Proteomics and Molecular Medicine (CAPMM)

https://capmm.gmu.edu/EN/

The Center for Applied Proteomics and Molecular Medicine at George Mason University focuses on the discovery and identification of biomarkers for early disease detection and risk assessment and the analysis of molecular pathways in diseased tissue to determine individualized and targeted treatment for patients. Results of the research will then be translated directly into patient management and care through clinical research and innovative clinical trials, with a vision toward creating a new paradigm to personalize medical treatment resulting in a positive impact on public health. *

	Group	George Mason University
	Industry	science

	City	n. a.
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2020-05-08

Picture Kenes Exhibitions Biomed Israel 2025 Tel Aviv 650x200px

More documents for George Mason University

[1] Fluidigm Corporation. (3/10/20). "Press Release: Fluidigm Introduces AccuLift Laser Capture Microdissection System to Advance Translational and Clinical Pathology Research". South San Francisco, CA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com